Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten.

导出 LinkOut

翻译打印收藏纠错

作者： Nosheen,Reza ^[1] ; Anandkumar,Dubey ^[2] ; Thomas,Carattini ^[2] ; Amy,Marzolf ^[3] ; Nicole,Hornsby ^[3] ; Alejandro,de Feria ^[3] ; Nadim,Mahmud ^[3] ; Patricia,Schuler ^[2] ; Anjali Tiku,Owens ^[4]

作者单位： Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: nosheen.reza@pennmedicine.upenn.edu. ^[1] Bristol Myers Squibb, Princeton, New Jersey, USA. ^[2] Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. ^[3] Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: anjali.owens@pennmedicine.upenn.edu. ^[4]

主题词人类(Humans);心肌病, 肥厚性(Cardiomyopathy, Hypertrophic);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);治疗结果(Treatment Outcome);老年人(Aged);回顾性研究(Retrospective Studies);苄胺类(Benzylamines);尿嘧啶(Uracil)

DOI 10.1016/j.jchf.2024.03.009

PMID 38661589

发布时间 2024-06-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JACC. Heart failure

2024年12卷6期

1123-1125页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten.

JACC. Heart failure

相似文献

JACC. Heart failure

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten.

JACC. Heart failure

相似文献

JACC. Heart failure

相关期刊

检索历史清除